Georges Gebrael

16PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPlanning and decision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Georges Gebrael, Neeraj Agarwal, Alicia K Morgans

|Jun 19, 2024
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.

Nishita Tripathi, Georges Gebrael, Beverly Chigarira

|May 23, 2024
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.

Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael

|Apr 17, 2024
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.

Eddy Saad, Georges Gebrael, Karl Semaan

|Apr 02, 2024
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.

Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas

|Apr 01, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.

Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh

Pageof 3

Frequent Collaborators

10 joint publications

Neeraj Agarwal

6 joint publications

Nicolas Sayegh

5 joint publications

Umang Swami

4 joint publications

Kamal Kant Sahu